Genofax is your dedicated partner in the pursuit of better health. Our mission is to empower you with the knowledge and tools needed to take control of your health. We provide easy-to-understand insights and tools for better health management. The Genofax Gut Status report makes this a reality. We're a life sciences company committed to improving global wellbeing with innovative healthcare solutions that leverage genetics, microbiome science, and AI. We're committed to providing personalized healthcare solutions for everyone, everywhere. We merge advanced AI technology, medical research, and scientific expertise to provide tailored solutions. Our interdisciplinary team has deep expertise in genetics, epigenetics, human nutrition, health, and medicine, and we possess patents in targeted microbiome-derived diagnosis.
Sydney, Australia
Founded in 2021
51-100 Employees
Medium-Sized
Working industry
Healthcare
Type of company
Manufacturer
Locations
1 Headquarter
Number of products
1 Product
Specialised areas
Health, Wellness & Fitness, Biotechnology, Biosicence
Genofax™ offers a wide range of products and services
Product
Genofax™ - A better way to Understanding of life and living organisms
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Australia
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
B
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Genofax™ operates in 1 country around the world
Get an overview of the locations of Genofax™
Location
Country
State
City
Headquarter
Australia
New South Wales
Sydney
Some frequent questions that have been asked about Genofax™
Where is Genofax™ located?
The company headquarter of Genofax™ is located in Sydney, New South Wales, Australia. It's worth noting, that the company may have more locations
How many employees does Genofax™ approximately have?
As of the latest available information Genofax™ has around 51-100 employees worldwide.
When was Genofax™ founded?
Genofax™ was founded in 2021
In which industries does Genofax™ mainly work?
The company Genofax™ has it's main focus in the industries of Healthcare
What is the current company status of Genofax™?
Based on the founding year and the amount of employees the company Genofax™ seems to be a Medium-Sized at the current state. Note that over time that status can change
Check out some interesting alternative companies to Genofax™
Fagron Genomics
Terrassa, Spain
11-50 Employees
2018
Fagron Genomics is an in vitro medical device global manufacturer specializing in the development and servicing of medical genetic algorithms. Manage the delivery of the information you request from us and, where appropriate, provide offers of products and / or services of Fagron Genomics, SLU in which you have expressed interest, 3. Our DNA is as unique as we are and helps define variations in our body's needs and capabilities. Understanding your genes will allow you and your healthcare provider to better define treatments to help improve therapeutic results. Innovative nutrigenomic algorithm to personalize your patient’s optimal diet and/or weight loss plan. Innovative biomarker of biological age evaluating telomere-related diseases. Provides personalized Acne treatment prescriptions to achieve optimal results.
GENETIX Healthcare Ltd
London, United Kingdom
1-10 Employees
2019
GENETIX Healthcare’s mission is to accelerate the transition to personalised, preventative health and wellness. We will do this by helping you access and understand your DNA, by accelerating access to point of care molecular diagnostics and by empowering you to make better decisions about your own health and wellness. GENETIX Healthcare is a company dedicated to the development of genetic and epigenetic products, point of care molecular diagnostic tools and services that unlock greater insight into your personalised and preventative health and wellness. We partner with world leading healthcare, biotechnology and molecular diagnostic companies to help deliver the future of healthcare, today. We believe the emergence and accelerating adoption of new and innovative technologies like genetic and epigenetic sequencing, artificial intelligence, blockchain, augmented reality and miniaturised, ultra-mobile molecular diagnostic platforms, will present fascinating opportunities for scientists, physicians, entrepreneurs, business and healthcare systems to improve patient outcomes and quality of life, improve efficiencies and reduce cost.
Genotix Biotechnologies Inc.
Sunnyvale, United States
1-10 Employees
2019
Our mission is to improve the lives of all people by providing accessible and reliable laboratory tests that help prevent disease and enhance wellness and longevity. Through the power of transformative miniaturization technology, Genotix Biotechnologies offers a simple biomedical device that provides greater accessibility to ultrasensitive biomarker characterization.
Geneyx
Herzliya, Israel
11-50 Employees
2018
Founded in 2018, Geneyx is driven by the belief that comprehensive genomic insights are essential for every patient’s care. Our mission is to transform the integration of genomics into healthcare and pharmaceutical research with our sophisticated data analysis platform. We are continuously enhancing the Geneyx platform with AI/ML tools and capabilities to streamline processes, substantially reduce turnaround times, increase accuracy, and ensure limitless scalability. Geneyx Analysis is a CE-IVD-certified platform for secondary and tertiary analysis of germline and somatic sequencing data interpretation. Geneyx Analysis promotes automation using APIs and batch upload features, which enable secure communication with LIMS and EHR systems and large sample workflows. Geneyx Analysis can also be implemented at any stage in the bioinformatic pipeline, Fastq or VCF, and provides detailed audit trails to monitor every step of the NGS pipeline. Geneyx Analysis includes reporting capabilities within the software and allows reports to be fully customizable, including rendering in different languages. Geneyx contributes significantly to various National Genome Projects.
OVERGENES SL
Paterna, Spain
1-10 Employees
-
Overgenes also has intestinal microbiota tests with the most advanced analysis technology on the market in which the presence or absence of multiple microorganisms associated with different pathologies, protection against diseases or with beneficial properties for health are analysed. The result of the Overgenes microbiota test allows, through a treatment based on supplements, prebiotics or probiotics, to correct the microbiota in weeks or a few months, obtaining a substantial improvement in the state and health, even allowing to modify the community associated with its old microbiota with predisposition to diseases and changing it into a protective microbiota against them. We are the provider of the most advanced genetic products with the greatest applicability and clinical utility for specialists and healthcare professionals. At Overgenes we are committed to scientific quality, evidence and the utmost rigour. Our team will support you about the products available and the process of operation. We will provide you with the devices and instructions for taking the sample.
Genoox
Palo Alto, United States
1-10 Employees
2014
Genoox uses the power of its community and combines public data with community data to streamline the path from DNA sample to clinical report – impacting patient care by making genomic data accessible and actionable at the point of care. Genoox enhances research and life sciences companies by providing an insight platform derived from real world data and evidence and powered by our community with robust genomic analytics – helping researchers simplify complex genomic data and make impactful discoveries using the most advanced genetic tools and applications. Genoox helps Biosystems companies such as DNA sequencing companies and Reagent providers to bundle its state of the art genomic engine with dedicated assays and instruments to bring a comprehensive solution for companion and clinical diagnostics. Genoox’s Platform provides a comprehensive solution for healthcare systems applications to investigate genetic variants on a wide scale in large population studies and countrywide genomic projects, streamlining access and newfound insights from genetic data via predictive modeling for evidence-based treatment protocols. Our mission is to create the largest real world evidence network of genomic and clinical data. The real-world evidence we produce enhances clinical decision-making, fine-tunes care pathways and enables more targeted therapies. If you’d like to chat about Genoox in more detail, complete this form and we’ll get back to you. Through our diverse and growing community, Genoox accumulates the most relevant data base and delivers actionable, real-world genomic insights that impact lives, improve clinical outcomes, and shape the business of healthcare.